Cargando…

Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology

Axonal damage leads to the release of neurofilament light chain (NFL), which enters the CSF or blood. In this work, an assay kit for plasma NFL utilizing immunomagnetic reduction (IMR) was developed. Antibodies against NFL were immobilized on magnetic nanoparticles to develop an IMR NFL kit. The pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Huei-Chun, Lin, Wei-Che, Chiu, Ming-Jang, Lu, Cheng-Hsien, Lin, Chin-Yi, Yang, Shieh-Yueh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292381/ https://www.ncbi.nlm.nih.gov/pubmed/32530970 http://dx.doi.org/10.1371/journal.pone.0234519

Ejemplares similares

Use of immunomagnetic reduction for C-reactive protein assay in clinical samples
por: Chang, Chien-Hsi, et al.
Publicado: (2012)

Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction
por: Chen, Hsin-Hsien, et al.
Publicado: (2022)

Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction
por: Liu, Huei-Chun, et al.
Publicado: (2021)

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease
por: Yang, Shieh-Yueh, et al.
Publicado: (2017)

Immunomagnetic Reduction Detects Plasma Aβ(1–42) Levels as a Potential Dominant Indicator Predicting Cognitive Decline
por: Yang, Shieh-Yueh, et al.
Publicado: (2020)

A Novel Detection Platform for Shrimp White Spot Syndrome Virus Using an ICP11-Dependent Immunomagnetic Reduction (IMR) Assay
por: Liu, Bing-Hsien, et al.
Publicado: (2015)

Long-Term Storage Effects on Stability of Aβ(1–40), Aβ(1–42), and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays
por: Chiu, Ming-Jang, et al.
Publicado: (2019)

Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods
por: Chang, Kuo-Hsuan, et al.
Publicado: (2021)

Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome
por: Wu, Chung-Hsin, et al.
Publicado: (2023)

Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD Drosophila Model
por: Su, Ming-Tsan, et al.
Publicado: (2022)

Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction
por: Wei, Po-Li, et al.
Publicado: (2018)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein over Repeated Freeze/Thaw Cycles
por: Liu, Huei-Chun, et al.
Publicado: (2020)

Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform
por: Lee, Stephen, et al.
Publicado: (2022)

Immunomagnetic nanoparticle-based assays for detection of biomarkers
por: Park, Hoyoung, et al.
Publicado: (2013)

Neurofilament light chain in the vitreous humor of the eye
por: Subramanian, Manju L., et al.
Publicado: (2020)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?
por: Thebault, Simon, et al.
Publicado: (2020)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Neurofilament light chain concentration in an aging population
por: Ladang, Aurélie, et al.
Publicado: (2022)

Blood neurofilament light chain in Parkinson’s disease
por: Buhmann, Carsten, et al.
Publicado: (2023)

Blood neurofilament light chain at the doorstep of clinical application
por: Leppert, David, et al.
Publicado: (2019)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Neurofilament Light Chain as A Biomarker for Brain Metastases
por: Winther-Larsen, Anne, et al.
Publicado: (2020)

Is CSF neurofilament light chain measurement relevant for MS?
por: Matsui, Makoto
Publicado: (2020)

Neurogranin and Neurofilament Light Chain as Preclinical Biomarkers in Scrapie
por: Betancor, Marina, et al.
Publicado: (2022)

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
por: Sjölin, Karl, et al.
Publicado: (2022)

Neurofilament light chain for classifying the aetiology of alteration of consciousness
por: Ongphichetmetha, Tatchaporn, et al.
Publicado: (2023)

Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
por: Kušnierová, Pavlína, et al.
Publicado: (2019)

Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma
por: Lin, Jonathan B, et al.
Publicado: (2023)

Evaluation of Immunomagnetic Separation for the Detection of Salmonella in Surface Waters by Polymerase Chain Reaction
por: Hsu, Chao-Yu, et al.
Publicado: (2014)

Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2023)

Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials
por: Ferreira, Pamela C.L., et al.
Publicado: (2023)

Neurofilament light: a narrative review on biomarker utility
por: Narayanan, Shilpa, et al.
Publicado: (2021)

Immunoliposome-based fluorometric patulin assay by using immunomagnetic nanoparticles
por: Song, Xinjie, et al.
Publicado: (2019)

Neurofilament light chain: a biomarker for genetic frontotemporal dementia
por: Meeter, Lieke H., et al.
Publicado: (2016)

Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
por: Sandelius, Åsa, et al.
Publicado: (2018)

Serum neurofilament light chain is increased in hereditary spastic paraplegias
por: Wilke, Carlo, et al.
Publicado: (2018)

Neurofilament light chain levels in MS: At the doorstep of clinical application
por: Dalmau, Josep
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tptk74ou0uv6k16llbfochquvs